PCRX logo

PCRX
Pacira BioSciences Inc

1,566
Mkt Cap
$919.12M
Volume
750,441.00
52W High
$27.64
52W Low
$18.80
PE Ratio
144.49
PCRX Fundamentals
Price
$22.70
Prev Close
$22.79
Open
$22.40
50D MA
$22.09
Beta
0.34
Avg. Volume
828,681.75
EPS (Annual)
$0.1562
P/B
1.35
Rev/Employee
$876,249.70
$1,345.47
Loading...
Loading...
News
all
press releases
Analysts Set Expectations for PCRX Q1 Earnings
Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) - Analysts at HC Wainwright issued their Q1 2027 earnings per share (EPS) estimates for shares of Pacira BioSciences in a note issued to investors...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Hennion & Walsh Asset Management Inc. Acquires 87,210 Shares of Pacira BioSciences, Inc. $PCRX
Hennion & Walsh Asset Management Inc. boosted its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 171.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 138,105 shares of the company's stock after purchasi...
MarketBeat·5d ago
News Placeholder
Pacira BioSciences, Inc. $PCRX Shares Purchased by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. grew its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 87.3% during the fourth quarter, according to the company in its most recent filing with...
MarketBeat·8d ago
News Placeholder
Pacira BioSciences (NASDAQ:PCRX) Price Target Cut to $25.00 by Analysts at Barclays
Barclays dropped their price target on Pacira BioSciences from $27.00 to $25.00 and set an "equal weight" rating on the stock in a report on Thursday...
MarketBeat·10d ago
News Placeholder
Pacira BioSciences (NASDAQ:PCRX) Insider Jonathan Slonin Sells 3,261 Shares
Pacira BioSciences, Inc. (NASDAQ:PCRX - Get Free Report) insider Jonathan Slonin sold 3,261 shares of Pacira BioSciences stock in a transaction dated Tuesday, March 17th. The stock was sold at an...
MarketBeat·16d ago
News Placeholder
Pacira BioSciences, Inc. (NASDAQ:PCRX) Receives Consensus Rating of "Hold" from Brokerages
Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Get Free Report) have been assigned a consensus recommendation of "Hold" from the six research firms that are currently covering the firm, Marketbeat...
MarketBeat·16d ago
News Placeholder
Insider Selling: Pacira BioSciences (NASDAQ:PCRX) Insider Sells 3,261 Shares of Stock
Pacira BioSciences, Inc. (NASDAQ:PCRX - Get Free Report) insider Jonathan Slonin sold 3,261 shares of the firm's stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $22.82, for a total value of $74,416.02. Following the completion of the transaction, the...
MarketBeat·16d ago
News Placeholder
Pacira BioSciences (NASDAQ:PCRX) Shares Down 4.7% - Time to Sell?
Pacira BioSciences (NASDAQ:PCRX) Stock Price Down 4.7% - Should You Sell...
MarketBeat·18d ago
News Placeholder
Radcliffe Capital Management L.P. Takes $1.23 Million Position in Pacira BioSciences, Inc. $PCRX
Radcliffe Capital Management L.P. bought a new position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F...
MarketBeat·22d ago
News Placeholder
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc. DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences...
PR Newswire·24d ago
<
1
2
...
>

Latest PCRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.